Latest filing published 03 Aug 2026 for Boston Scientific CORP, €2.6M. Read the official filing
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Joseph Michael Fitzgerald across 2 companies, led by Boston Scientific Corp and Chain Bridge Bancorp Inc. We count 53 filings; the first trade dates from 1 January 2016 and the latest from 31 July 2026.
Market trades split into 2 purchases (€29k) and 7 sales (€17.1M). Netting one side against the other leaves €17.0M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 4 share grants and 25 option exercises.
On 3 August 2026 came the latest disclosure, a transaction for €2.6M in Boston Scientific Corp. The last insider purchase was made public on 13 February 2025, 612 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 53 declarations